Uganda Pharmaceuticals & Healthcare Q4 2018
Fundamental barriers in Uganda's pharmaceutical and healthcare sector will limit the attractiveness to multinationaldrugmakers. Low affordability levels will ensure low-cost generic drugs remain dominant, while the government plans to localisedrug production to boost medicine sustainability. While the market has brighter long-term prospects, multinational drugmakerappetite will remain subdued despite the positive economic growth forecast over the coming years.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook